Table 3.

HRQoL measures of the survivors between the two groups.

SF-36 scores (IQR)	MRD-HSCT(n = 45)	Haplo-cord HSCT(n = 49)	P
Physical
Physical component summary	79.3 (69.3–83.8)	84.3 (76.1–91.7 )	0.002
Physical functioning	90.0 (80.0–95.0)	95.0 (90.0–95.0)	0.001
Role-physical functioning	75.0 (50.0–75.0)	75.0 (50.0–100.0)	0.096
Bodily pain	100.0 (100.0–100.0)	100.0 (95.5–100.0)	0.170
General health	57.0 (42.0–67.5)	67.0 (62.0–72.0)	< 0.001
Psychological
Mental component summary	90.1 (84.4–92.4)	90.0 (84.9–96.4)	0.233
Vitality	85.0 (75.0–90.0)	85.0 (77.5–90.0)	0.651
Social functioning	87.5 (75.0–87.5)	100.0 (87.5–100.0)	< 0.001
Role-emotional functioning	100.0 (100.0–100.0)	100.0 (100.0–100.0)	0.950
Mental health	88.0 (84.0–92.0)	88.0 (82.0–88.0)	0.147

Haplo-cord HSCT, haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion; MRD-HSCT, matched related donor hematopoietic stem cell transplantation; HRQoL, health-related quality of life; IQR, interquartile range.

The bold values were statistically significant (P < 0.05).